Oropharyngeal CancerФаза 2NCT06445114
Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Cisplatin
41 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Head and neck41 studies
Oropharyngeal CancerФаза 2NCT06445114
Cisplatin
Oral Cavity Squamous Cell CarcinomaФаза 2NCT07121595
Biospecimen Collection, Carboplatin, Cisplatin, Computed Tomography
Locally Recurrent Oral Cavity Squamous Cell CarcinomaФаза 2NCT06448026
Cemiplimab, Cetuximab
HPV-Related Oropharynx Squamous Cell CarcinomaФаза 2NCT06702033
Radiation therapy, Cisplatin, Surgery
Oropharynx CancerФаза 2NCT05388773
therapeutic conventional surgery, laboratory biomarker analysis, quality-of-life assessment, intensity-modulated radiation therapy
Oropharyngeal Squamous Cell CarcinomaФаза 2NCT04852328
CUE-101
Head and Neck Squamous Cell CarcinomaФаза 2NCT04375384Papers
Cetuximab, Questionnaire administration, Quality of life assessment
Head and Neck CancerФаза 2NCT07179315
cemiplimab+fianlimab, Cemiplimab
GlandФаза 2NCT05884320Papers
Sacituzumab Govitecan
Metastatic Oropharyngeal CarcinomaФаза 2NCT05799144
DNA Vaccine, Human Papillomavirus Tumor Antigen Vaccine, Pembrolizumab, Computed Tomography (CT)
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Фаза 2NCT07178301
Computed Tomography, Nasopharyngeal Laryngoscopy, Positron Emission Tomography, Questionnaire Administration
Advanced Head and Neck Squamous Cell CarcinomaФаза 2NCT07094685
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab
Nasopharyngeal CarcinomaФаза 2NCT06592599
Toripalimab, Concurrent Chemoradiation and Adjuvant treatment following Chemoradiation
Head and Neck Squamous Cell CarcinomaФаза 2NCT05726370
Pembrolizumab, CISPLATIN, Carboplatin, Docetaxel
Squamous Cell Carcinoma of Head and NeckФаза 2NCT05317000Papers
Combination 5-azacytidine and nivolumab, Nivolumab
Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 1NCT07455032
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaPhase 1NCT06868433
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer